Background: Interstitial pneumonia with autoimmune features (IPAF) identifies a recently recognized autoimmune syndrome characterized by interstitial lung disease and autoantibodies positivity, but absence of a specific connective tissue disease diagnosis or alternative etiology. We retrospectively reviewed the clinical presentation, diagnostic workup and management of seven critically ill patients who met diagnostic criteria for IPAF. We compared baseline characteristics and clinical outcome of IPAF patients with those of the population of ARDS patients admitted in the same period. Results: Seven consecutive patients with IPAF admitted to intensive care unit for acute respiratory distress syndrome (ARDS) were compared with 78 patients with ARDS secondary to a known risk factor and with eight ARDS patients without recognized risk factors. Five IPAF patients (71%) survived and were discharged alive from ICU: Their survival rate was equal to that of patients with a known risk factor (71%), while the subgroup of patients without risk factors had a markedly lower survival (38%). According to the Berlin definition criteria, ARDS was severe in four IPAF patients and moderate in the remaining three. All had multiple organ dysfunction at presentation. The most frequent autoantibody detected was anti-SSA/Ro52. All patients required prolonged mechanical ventilation (median duration 49 days, range 10–88); four received extracorporeal membrane oxygenation and one received low-flow extracorporeal CO2 removal. All patients received immunosuppressive therapy. Conclusions: This is the first description of a cohort of critical patients meeting the diagnostic criteria for IPAF presenting with ARDS. This diagnosis should be considered in any critically ill patient with interstitial lung disease of unknown origin. While management is challenging and level of support high, survival appears to be good and comparable to that of patients with ARDS associated with a known clinical insult.

Grasselli, G., Vergnano, B., Pozzi, M., Sala, V., Dâ andrea, G., Scaravilli, V., et al. (2017). Interstitial pneumonia with autoimmune features: an additional risk factor for ARDS?. ANNALS OF INTENSIVE CARE, 7(1) [10.1186/s13613-017-0320-3].

Interstitial pneumonia with autoimmune features: an additional risk factor for ARDS?

GRASSELLI, GIACOMO
Primo
;
VERGNANO, BEATRICE
Secondo
;
POZZI, MARIA ROSA;SALA, VITTORIA LUDOVICA;SCARAVILLI, VITTORIO;MANTERO, MARCO;PESCI, ALBERTO
Penultimo
;
PESENTI, ANTONIO MARIA
Ultimo
2017

Abstract

Background: Interstitial pneumonia with autoimmune features (IPAF) identifies a recently recognized autoimmune syndrome characterized by interstitial lung disease and autoantibodies positivity, but absence of a specific connective tissue disease diagnosis or alternative etiology. We retrospectively reviewed the clinical presentation, diagnostic workup and management of seven critically ill patients who met diagnostic criteria for IPAF. We compared baseline characteristics and clinical outcome of IPAF patients with those of the population of ARDS patients admitted in the same period. Results: Seven consecutive patients with IPAF admitted to intensive care unit for acute respiratory distress syndrome (ARDS) were compared with 78 patients with ARDS secondary to a known risk factor and with eight ARDS patients without recognized risk factors. Five IPAF patients (71%) survived and were discharged alive from ICU: Their survival rate was equal to that of patients with a known risk factor (71%), while the subgroup of patients without risk factors had a markedly lower survival (38%). According to the Berlin definition criteria, ARDS was severe in four IPAF patients and moderate in the remaining three. All had multiple organ dysfunction at presentation. The most frequent autoantibody detected was anti-SSA/Ro52. All patients required prolonged mechanical ventilation (median duration 49 days, range 10–88); four received extracorporeal membrane oxygenation and one received low-flow extracorporeal CO2 removal. All patients received immunosuppressive therapy. Conclusions: This is the first description of a cohort of critical patients meeting the diagnostic criteria for IPAF presenting with ARDS. This diagnosis should be considered in any critically ill patient with interstitial lung disease of unknown origin. While management is challenging and level of support high, survival appears to be good and comparable to that of patients with ARDS associated with a known clinical insult.
Articolo in rivista - Articolo scientifico
ARDS; ECMO; Interstitial pneumonia with autoimmune features; Lung-dominant connective tissue disease; Critical Care and Intensive Care Medicine
English
Grasselli, G., Vergnano, B., Pozzi, M., Sala, V., Dâ andrea, G., Scaravilli, V., et al. (2017). Interstitial pneumonia with autoimmune features: an additional risk factor for ARDS?. ANNALS OF INTENSIVE CARE, 7(1) [10.1186/s13613-017-0320-3].
Grasselli, G; Vergnano, B; Pozzi, M; Sala, V; Dâ andrea, G; Scaravilli, V; Mantero, M; Pesci, A; Pesenti, A
File in questo prodotto:
File Dimensione Formato  
10281-173464.pdf

accesso aperto

Tipologia di allegato: Publisher’s Version (Version of Record, VoR)
Dimensione 959.43 kB
Formato Adobe PDF
959.43 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/173464
Citazioni
  • Scopus 10
  • ???jsp.display-item.citation.isi??? 9
Social impact